"If we can try to slow down that rapid weight loss a little bit, then as we're losing weight, we maintain adequate muscle mass by doing light resistance training and meeting protein needs," said Zumpano.
Click here to read the At Issue to this Cover Story.
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials
Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53
These risks underline the importance of patient selection, careful monitoring about tolerability and safety when initiating therapy with semaglutide
[DOI] [PubMed] [Google Scholar] 6.Han K, et al